...
首页> 外文期刊>Physiological Research >Parathyroid imaging by 18F-fluorocholine PET/CT in patients with primary hyperparathyroidism and inconclusive conventional methods: clinico-pathological correlations.
【24h】

Parathyroid imaging by 18F-fluorocholine PET/CT in patients with primary hyperparathyroidism and inconclusive conventional methods: clinico-pathological correlations.

机译:原发性甲状旁腺功能亢进和常规方法尚无定论的患者通过18F-氟胆碱PET / CT进行甲状旁腺显像:临床病理相关性。

获取原文
           

摘要

18F-fluorocholine positron emission tomography/computedtomography (FCH) was performed after inconclusive neckultrasound and 99Tc-sestaMIBI SPECT (MIBI) scintigraphy inpatients with primary hyperparathyroidism (PHPT) to localizeabnormal parathyroid glands before surgery. The results wereretrospectively evaluated and compared to postoperativehistopathological findings. 13 patients with PHPT were enrolled(mean age 64.3 years, preoperative calcium 2.74 mmol/l andparathyroid hormone 114.6 ng/l). FCH localized hyperfunctioningparathyroid glands in 12 patients of 13 (per patient sensitivity92 % and positive predictive value (PPV) 100 %). Fourteenparathyroid lesions (11 adenomas, 3 hyperplastic glands) wereresected with a mean size of 11.9 mm (per lesion sensitivity93 % and PPV 81 %). Four adenomas and one hyperplastic glandwere composed of only chief cells, whereas five lesions containedboth chief and oxyphil cells. In three patients an exclusivelyoxyphil adenoma was found, surprisingly with negative MIBIscintigraphy in spite of a high mitochondria content in the oxyphilparathyroid cells. 12 of 13 patients had thyroid disease. In ourlimited study sample, FCH correctly identified parathyroidadenomas and/or hyperplastic glands in 92 % of patients withpreviously inconclusive conventional imaging. Unlike MIBI, FCHsuccessfully localized small, hyperplastic and multiplehyperfunctioning parathyroid glands, irrespective of theirhistopathological composition.
机译:不确定的颈部超声检查和99Tc-sestaMIBI SPECT(MIBI)闪烁显像患者的原发性甲状旁腺功能亢进症(PHPT)患者在手术前进行了18F-氟胆碱正电子发射断层扫描/计算机断层扫描(FCH)术。对结果进行回顾性评估,并将其与术后组织病理学发现进行比较。入选13例PHPT患者(平均年龄64.3岁,术前钙2.74 mmol / l,甲状旁腺激素114.6 ng / l)。 FCH局限性甲状旁腺功能亢进症在12例患者中占13例(每例患者的敏感性为92%,阳性预测值(PPV)为100%)。切除了十四个甲状旁腺病变(11个腺瘤,三个增生腺),平均大小为11.9 mm(每个病变的敏感性为93%,PPV为81%)。四个腺瘤和一个增生性腺仅由主细胞组成,而五个病变包含主细胞和嗜氧细胞。在三例患者中,发现了一个唯一的嗜氧性腺瘤,尽管在甲状旁腺甲状旁腺细胞中线粒体含量很高,但MIBI闪烁显像阴性。 13名患者中有12名患有甲状腺疾病。在我们有限的研究样本中,FCH正确地鉴定了92%以前尚无定论的常规影像学检查的患者的甲状旁腺腺瘤和/或增生腺。与MIBI不同,FCH成功地定位了小的,增生性和功能亢进的甲状旁腺,而不论其组织病理学组成如何。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号